Clinical trial
Post Marketing Surveillance for General Drug Use to Assess the Safety and Efficacy Profile of ELONVA in Usual Practice
NCT01408615 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance for General Drug Use to Assess the Safety and Efficacy Profile of ELONVA in Usual Practice
- Lead sponsor
- Organon and Co
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2011
- Completion date
- November 18, 2016
- Enrollment
- 472 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.